Eleva is a clinical-stage biopharmaceutical company developing novel therapies and unlocking difficult-to-produce biologics based on a transformative manufacturing platform.
The company’s innovative drug development activities currently focus on complement disorders and enzyme replacement therapies, with wider potential across a range of disease areas.